BioCryst Pharmaceuticals shares owned by Vanguard Asset Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Vanguard Asset Management
from 13F filings
Historical chart of Vanguard Asset Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Vanguard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.9M | 196k | 9.52 |